静脉注射免疫球蛋白是一种有效的类固醇节约药物,用于炎症性肌肉炎的治疗
Agnes Nannarup1, Lars Erik Bartels1, Esben Uggerby Næser1
1Department of Rheumatology, Aarhus University Hospital, Denmark.
Danish medical journal
|November 28, 2025
概括
静脉注射免疫球蛋白 (IVIG) 通过减少类固醇依赖和改善症状,有效治疗异常性炎症性肌肉炎 (IIM). 这种疗法提供了显著的功能恢复,可以在IIM治疗中提前考虑使用.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 神经学 神经学
背景情况:
- 异常性炎症性肌肉炎 (IIM) 主要用葡萄糖皮质类药物治疗,这些药物具有显著的长期副作用.
- 静脉注射免疫球蛋白 (IVIG) 为IIM提供了潜在的类固醇节省替代品,特别是在耐火病例中.
研究的目的:
- 评估IVIG作为IIM患者的类固醇节约治疗的疗效.
- 评估IVIG对肌肉炎相关症状,功能能力和葡萄糖皮质体剂量的影响.
主要方法:
- 在2018年8月至2023年8月期间接受IVIG的22名IIM成年患者的回顾性队列研究.
- 评估的结果包括肌肉炎症状的变化,功能测试,肌酸激酶 (CK) 水平和3个月和6个月的普雷尼索隆剂量.
主要成果:
- 经过六个月的时间,在失消症 (87.5%) 和心脏症状 (100%) 中发现了显著的改善.
- 功能性能和CK水平显著改善,六个月后,每日平均普得尼索隆剂量减少了77% (从44.7毫克降至9.9毫克).
- 最常见的IIM亚型是多肌性炎 (36%),免疫媒介性化肌病 (23%),以及皮肤肌性炎 (18%).
结论:
- IVIG是一种有效的类固醇节约治疗IIM,导致减少葡萄糖皮质醇的使用和改善临床结果.
- 这些发现支持在IIM治疗过程中早期考虑IVIG,特别是在对葡萄糖皮质类药物有禁忌的患者中.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
413
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
413
01:29Inflammatory Bowel Disease IV: Pharmacological Management
450
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
450
01:20Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
01:14Myocarditis III: Medical Management
162
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
162
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K